ConductScience.org, home
Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab
API referenceFor AI assistants

Trial · NCT01544595

Participant flow36

How many started, completed or left each group, period by period.

1 to 20 of 36

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Status at Week 68STARTEDAIN457 150 mg -Randomized Withdrawal Period301
Status at Week 68STARTEDAIN457 300 mg -Randomized Withdrawal Period363
Status at Week 68STARTEDAIN457 150 mg Placebo - Randomized Withdrawal Period150
Status at Week 68STARTEDAIN457 300 mg Placebo - Randomized Withdrawal Period181
Status at Week 68STARTEDAIN457 150 mg - Partial Responders0
Status at Week 68STARTEDAIN457 300 mg - Partial Responders0
Status at Week 68COMPLETEDAIN457 150 mg -Randomized Withdrawal Period262
Status at Week 68COMPLETEDAIN457 300 mg -Randomized Withdrawal Period346
Status at Week 68COMPLETEDAIN457 150 mg Placebo - Randomized Withdrawal Period87
Status at Week 68COMPLETEDAIN457 300 mg Placebo - Randomized Withdrawal Period130
Status at Week 68COMPLETEDAIN457 150 mg - Partial Responders0
Status at Week 68COMPLETEDAIN457 300 mg - Partial Responders0
Status at Week 68NOT COMPLETEDAIN457 150 mg -Randomized Withdrawal Period39
Status at Week 68NOT COMPLETEDAIN457 300 mg -Randomized Withdrawal Period17
Status at Week 68NOT COMPLETEDAIN457 150 mg Placebo - Randomized Withdrawal Period63
Status at Week 68NOT COMPLETEDAIN457 300 mg Placebo - Randomized Withdrawal Period51
Status at Week 68NOT COMPLETEDAIN457 150 mg - Partial Responders0
Status at Week 68NOT COMPLETEDAIN457 300 mg - Partial Responders0
Status at Week 156STARTEDAIN457 150 mg -Randomized Withdrawal Period301
Status at Week 156STARTEDAIN457 300 mg -Randomized Withdrawal Period363

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01544595/flow

API referenceFor AI assistants